Clinical Trials Logo

Filter by:
NCT ID: NCT03819556 Recruiting - Milk Allergy Clinical Trials

Swedish Study of Immunotherapy for Milk Allergy in Children

SWITCH
Start date: April 20, 2018
Phase: N/A
Study type: Interventional

This trial is a two-armed open randomized controlled trial in children aged 5-15 years with challenge proven Immunoglobulin E (IgE)-associated milk allergy.The purpose is to determine if oral immunotherapy with milk can induce tolerance to milk. The active intervention is intake of increasing amounts of fresh milk for six months followed by three years of maintenance treatment with milk. The control group continues their elimination (milk free) diet. The trial will recruit patients at ten pediatric departments in Sweden, coordinated by Umeå University. The primary outcome is milk tolerance (defined as a negative double-blind placebo-controlled milk challenge) at trial completion 3.5 years after start of treatment. Secondary outcomes include allergic symptoms during treatment documented as certain allergic manifestations, changes in immunological and microbial biomarkers, quality of life and nutritional status.

NCT ID: NCT03830515 Recruiting - Wounds Clinical Trials

Evaluation of microMend Device to Close Lacerations

Start date: April 20, 2018
Phase: N/A
Study type: Interventional

In this study, total of 20 subjects will have lacerations will be closed with microMend, which is an FDA-listed wound closure product. microMend is a wound closure device that is the size and shape of a butterfly bandage and incorporates tiny Microstaples into an adhesive backing. Assessments by practitioners and Subjects of microMend will be made at Days 0 10, and 3 months using a combination of questionnaires and photographs.

NCT ID: NCT04252924 Recruiting - Physical Activity Clinical Trials

Habits, Orthorexia Nervosa and LIfestyle in STudents

HOLISTic
Start date: April 20, 2018
Phase:
Study type: Observational

Non-communicable diseases (NCDs) compose a substantial proportion of the global burden of diseases, posing a significant challenge in both high-income and low- and middle-income countries. In particular, certain lifestyle-related risk factors, such as unhealthy diet, physical inactivity, smoking, excessive alcohol consumption, and sleep deprivation are the leading risk factors, which place people at an increased risk of developing NCDs. On the other hand, a growing phenomenon of excessive concern about diet and health is emerging, and it is contributing to the development of a novel eating behavior disorder named orthorexia nervosa. According to recent studies, orthorexic behavior is very common among young adults and especially so in health-care professionals. The main objective of this multi-center study is to explore and compare lifestyle habits among undergraduate medical students and other healthcare-related professions from different countries (Croatia, Lebanon, Italy, Poland, Spain, and Turkey). The goal is to obtain information on the presence of unhealthy habits in order to be able to intervene, offering the information needed for primordial disease prevention in this young and still healthy group of respondents, who are the health educators and role models of the future. The particular importance of this goal is to raise awareness of the problem of the ubiquitously present unhealthy lifestyles. Unfortunately, health-care students are not the exception regarding the prevalence of the unhealthy diet, sedentary behavior, sleep deprivation and high levels of psychological stress. Furthermore, the adoption of unhealthy lifestyle patterns in health-care workers, such as doctors and nurses, will have far-reaching negative consequences, in both their health and their patients' health. The results of this study will be used for identifying the needs and targets for intervention, enabling students to become a pillar of health education for their patients and the population in general.

NCT ID: NCT03899415 Recruiting - Clinical trials for Hepatocellular Carcinoma

TCR-Redirected T Cells Therapy in Patient With HBV Related HCC

Start date: April 20, 2019
Phase: Phase 1
Study type: Interventional

This is a single center. single arm, open-label study to determine the safety and clinical benefit of TCR-redirected T cell therapy in patient with HBV related HCC post hepatectomy or radiofrequency ablation.

NCT ID: NCT03916679 Recruiting - Ovarian Cancer Clinical Trials

MESO-CAR T Cells Therapy for Relapsed and Refractory Epithelial Ovarian Cancer

Start date: April 20, 2019
Phase: Phase 1/Phase 2
Study type: Interventional

The goal of this clinical trial is to study the feasibility and efficacy of anti-MESO antigen receptors (CARs) T cell therapy for relapsed and refractory epithelial ovarian cancer.

NCT ID: NCT03932357 Recruiting - Clinical trials for Cone Beam Computed Tomography

Measuring Soft Tissue Thickness by CBCT

Start date: April 20, 2019
Phase:
Study type: Observational

accuracy of CBCT in measuring soft tissue thickness by using a radiopaque material as the real finding and measurements on pig jaws

NCT ID: NCT05040399 Recruiting - Clinical trials for Surgical Site Infection

Sternal Wound Infection in Patients Undergone Sternal Fixation Using Locking Compression Plates

Start date: April 20, 2019
Phase: N/A
Study type: Interventional

Sternal Wound Infection (SWI) in open heart surgery is one of the most annoying and avoidable complications that one encounters during work. Investigators investigate the rates of sternal wound infection (SWI) in patients in whom were used locking compression plates (LCP) versus in patients in whom were used wires to fixate the sternum for variable causes. SWI increases the overall cost and burden in the medical service and increases the patients suffering and disability. investigators aim to provide our patients with the most suitable means for sternal fixation.

NCT ID: NCT05073640 Recruiting - Schizophrenia Clinical Trials

Pentoxifylline Add-on Therapy for Schizophrenia

Start date: April 20, 2019
Phase: Phase 1/Phase 2
Study type: Interventional

The etiology and pathogenesis of schizophrenia remain unclear. The immune dysfunction hypothesis for schizophrenia has attracted increasing attention from researchers, and substantial evidence suggested that the levels of TNF-α and other cytokines are markedly elevated in patients with schizophrenia. The investigators aim to evaluate the adjuvant therapeutic effect of Pentoxifylline, a TNF-α inhibitor that crosses the blood-brain barrier, in a randomized, double-blind, 6-week trial. Individuals with schizophrenia will receive either Pentoxifylline or a matching placebo as an add-on treatment to antipsychotic agents. Subjects' positive and negative symptoms and plasma concentration of neuroinflammatory markers will be monitored at baseline and every two weeks until the end of the trial.

NCT ID: NCT03788096 Recruiting - Sepsis Clinical Trials

Peer Support for Post Intensive Care Syndrome Self-Management

PS-PICS
Start date: April 20, 2020
Phase: N/A
Study type: Interventional

A prospective, 2-arm, single-blind, randomized controlled clinical feasibility trial design is planned. Forty CCI survivors will be randomized (1:1) to either the PS-PICS (peer support) intervention or usual care (control) group.

NCT ID: NCT04195269 Recruiting - Pain Clinical Trials

Osteoarthritis of the Knee Pain Study Using a CBD and THC Sublingual Tablet

Start date: April 20, 2020
Phase: Phase 2
Study type: Interventional

This study is a prospective Phase 2, drug controlled, open-label study to evaluate the safety and efficacy of Pure Green sublingual tablets for the treatment of pain associated with osteoarthritis of the knee.